NutriBand Inc. (NTRB) stock
NTRBNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 4/30225% above fair value
$5.59−0.22 (-3.79%)
Close on Nov 17, 2026Market cap $67.95MP/E –Yield –
NutriBand operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
NutriBand's operating cash flow for the twelve months ending Jul 31, 2026 was -$3.63M. For fiscal 2026 it was -$5.13M. The highest annual figure on record is -$92.86K in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | -$5.13M | – |
| FY2025 | Jan 31, 2025 | -$4.63M | – |
| FY2024 | Jan 31, 2024 | -$3.53M | – |
| FY2023 | Jan 31, 2023 | -$2.99M | – |
| FY2022 | Jan 31, 2022 | -$2.81M | – |
| FY2021 | Jan 31, 2021 | -$297.06K | – |
| FY2020 | Jan 31, 2020 | -$894.47K | – |
| FY2019 | Jan 31, 2019 | -$1.11M | – |
| FY2018 | Jan 31, 2018 | -$92.86K | – |
| FY2017 | Jan 31, 2017 | -$147.92K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | -$585.00K | – |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | -$563.10K | – |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | -$731.83K | – |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | -$1.75M | – |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | -$1.31M | – |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | -$1.34M | – |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | -$1.24M | – |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | -$1.01M | – |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | -$1.54M | – |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | -$833.93K | – |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | -$718.24K | – |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | -$1.06M | – |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | -$995.14K | – |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | -$749.86K | – |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | -$814.01K | – |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | -$520.44K | – |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | -$908.49K | – |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | -$744.26K | -846.2% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | -$1.23M | – |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | -$279.42K | – |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | -$83.15K | – |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $99.74K | – |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | -$112.14K | – |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | -$201.51K | – |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | -$117.54K | – |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | -$266.36K | – |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | -$238.02K | – |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | -$272.55K | – |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | -$282.89K | – |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | -$439.63K | – |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | -$355.50K | – |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | -$27.44K | – |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | -$11.40K | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | -$22.73K | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | -$30.65K | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | -$28.08K | – |
| Q4 FY2017CQ4 2016 | Jan 31, 2017 | -$32.08K | – |
| Q3 FY2017CQ3 2016 | Oct 31, 2016 | -$15.52K | – |
| Q2 FY2017CQ2 2016 | Jul 31, 2016 | -$45.12K | – |
See a number that looks wrong?